An Improved Protocol for Regioselective Ring-Opening of Sulfonyl Aziridines with Iodine
TOF mass spectrometer. IR spectra were recorded as
thin films or as solids in KBr pellets on a Perkin-Elmer
FT210 spectrophotometer. Melting points were deter-
mined on a digital melting point apparatus and tem-
peratures were uncorrected.
NMR (400 MHz, d6-DMSO) δ: 8.09 (t, J=6.0 Hz, 1H),
7.65 (d, J=8.0 Hz, 2H), 7.43 (s, 1H), 7.36-7.16 (m,
5H), 5.16-5.13 (m, 1H), 3.49-3.45 (m, 2H), 2.36 (s,
3H); 13C NMR (100 MHz, CDCl3) δ: 143.8, 143.2,
138.0, 133.5, 130.8, 130.1, 128.4, 128.0, 127.0, 126.8,
50.6, 29.4, 21.4; IR (KBr) v: 3287, 2925 cm−1; HRMS
(ESI) calcd for C15H1635ClINO2S (M+H)+ 435.9635;
found 435.9631.
General procedure for the preparation of β-iodo-
amines or iodohydrins
To a solution of aziridines 1 or epoxide 3 (0.20
mmol) and iodine (0.10 mmol) in CH2Cl2 (2.0 mL) was
added PPh3 (0.10 mmol), and the reaction mixture was
stirred at room temperature in 1 min. Then the mixture
was purified directly by flash column chromatography
on silica gel to afford the corresponding product.
N-(2-Iodo-2-phenylethyl)-4-methylbenzenesulfon-
amide (2a)[9a] 1H NMR (400 MHz, CDCl3) δ: 7.72 (d,
J=8.0 Hz, 2H), 7.33 (d, J=8.0 Hz, 2H), 7.26 (s, 5H),
5.04 (t, J=7.6 Hz, 1H), 4.97 (t, J=6.4 Hz, 1H), 3.73-
3.66 (m, 1H), 3.55-3.48 (m, 1H), 2.45 (s, 3H); 13C
NMR (75 MHz, CDCl3) δ: 143.8, 139.9, 137.0, 129.9,
129.0, 128.7, 127.5, 127.0, 51.2, 29.9, 21.6.
N-(2-(3-Bromophenyl)-2-iodoethyl)-4-methylben-
zenesulfonamide (2h) White solid 122-125 ℃; 1H
NMR (400 MHz, d6-DMSO) δ: 8.09 (t, J=6.0 Hz, 1H),
7.65 (d, J=8.0 Hz, 2H), 7.55 (s, 1H), 7.43-7.34 (m,
4H), 7.24 (d, J=8.0 Hz, 1H), 5.15-5.11 (m, 1H),
3.48-3.45 (m, 2H), 2.36 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ: 144.1, 143.2, 138.0, 131.3, 131.1, 130.8,
130.1, 127.4, 126.8, 122.0, 50.7, 29.4, 21.4; IR (KBr) v:
3287, 2925 cm−1; HRMS (ESI) calcd for C15H1679Br-
INO2S (M+H)+ 479.9130; found 479.9126.
N-(2-Iodo-2-(naphthalen-2-yl)ethyl)-4-methylben-
1
zenesulfonamide (2i) White solid 141-142 ℃; H
NMR (400 MHz, d6-DMSO) δ: 8.12 (t, J=6.0 Hz, 1H),
7.86-7.84 (m, 4H), 7.66 (d, J=8.0 Hz, 2H), 7.51-
7.49 (m, 3H), 7.32 (d, J=8.0 Hz, 2H), 5.38-5.34 (m,
1H), 3.62-3.55 (m, 2H), 2.33 (s, 3H); 13C NMR (100
MHz, CDCl3) δ: 143.2, 138.7, 138.1, 133.0, 130.0,
128.8, 128.3, 127.9, 126.9, 126.9, 126.8, 126.5, 126.3,
50.9, 32.3, 21.4; IR (KBr) v: 3278, 2930 cm−1; HRMS
(EI) calcd for C19H18NO2S (M+−I) 324.1058; found
324.1054.
N-(2-Iodooctyl)-4-methylbenzenesulfonamide
(2j)[11] 1H NMR (400 MHz, CDCl3) δ: 7.79 (d, J=8.0
Hz, 2H), 7.31 (d, J=8.0 Hz, 2H), 5.00 (d, J=8.0 Hz,
1H), 3.26-3.15 (m, 2H), 2.98-2.94 (m, 2H), 2.42 (s,
3H), 1.49-1.34 (m, 2H), 1.25-1.05 (m, 8H), 0.85 (t,
J=7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 143.5,
137.8, 129.7, 127.0, 52.7, 35.3, 31.5, 28.6, 25.1, 22.4,
21.5, 14.4, 14.0.
N-(2-Iodocyclohexyl)-4-methylbenzenesulfonamide
(2k)[9a] 1H NMR (400 MHz, CDCl3) δ: 7.81 (d, J=8.0
Hz, 2H), 7.32 (d, J=8.0 Hz, 2H), 5.26 (d, J=6.4 Hz,
1H), 4.02-3.97 (m, 1H), 3.31-3.27 (m, 1H), 2.42 (s,
3H), 2.35-2.33 (m, 1H), 2.19-2.16 (m, 1H), 1.99-
1.89 (m, 1H), 1.68-1.66 (m, 1H), 1.53-1.50 (m, 1H),
1.41-1.22 (m, 3H); 13C NMR (100 MHz, CDCl3) δ:
143.5, 137.4, 129.6, 127.3, 59.1, 34.9, 32.9, 29.6, 26.5,
26.5, 21.5.
4-Chloro-N-(2-iodo-2-phenylethyl)benzenesulfon-
amide (2l) White solid 151-153 ℃; 1H NMR (400
MHz, d6-DMSO) δ: 8.26 (t, J=6.0 Hz, 1H), 7.78 (d,
J=8.8 Hz, 2H), 7.62 (d, J=8.8 Hz, 2H), 7.38 (d, J=
7.2 Hz, 2H), 7.30-7.21 (m, 3H), 5.19-5.15 (m, 1H),
3.55-3.40 (m, 2H); 13C NMR (100 MHz, CDCl3) δ:
141.3, 139.8, 137.8, 129.8, 129.0. 128.8, 128.6, 128.1,
50.9, 31.7; IR (KBr) v: 3291, 2923 cm−1; HRMS (EI)
calcd for C14H1335ClNO2S (M+ −I) 294.0356; found
294.0354.
N-(2-(4-Fluorophenyl)-2-iodoethyl)-4-methylben-
1
zenesulfonamide (2b) White solid 141-143 ℃; H
NMR (400 MHz, d6-DMSO) δ: 8.05 (t, J=5.6 Hz, 1H),
7.65 (d, J=8.4 Hz, 2H), 7.44-7.40 (m, 2H), 7.36 (d,
J=8.4 Hz, 2H), 7.13-7.08 (m, 2H), 5.20-5.16 (m,
1H), 3.49-3.36 (m, 2H), 2.36 (s, 3H); 13C NMR (100
MHz, CDCl3) δ: 163.1 (d, J=243.8 Hz), 143.2, 138.0,
137.8 (d, J=3.2 Hz), 130.3 (d, J=8.4 Hz), 130.1, 126.8,
115.9 (d, J=21.4 Hz), 51.1, 30.5, 21.4; IR (KBr) v:
3280, 2925 cm−1; HRMS (EI) calcd for C15H15FNO2S
(M+−I): 292.0808; found 292.0803.
N-(2-(4-Chlorophenyl)-2-iodoethyl)-4-methylben-
zenesulfonamide (2c)[9a]
1H NMR (400 MHz,
d6-DMSO) δ: 8.05 (t, J=5.6 Hz, 1H), 7.64 (d, J=8.4
Hz, 2H), 7.40 (d, J=8.4 Hz, 2H), 7.35-7.31 (m, 4H),
5.17-5.13 (m, 1H), 3.47-3.39 (m, 2H), 2.36 (s, 3H);
13C NMR (100 MHz, CDCl3) δ: 143.2, 140.5, 138.0,
132.9, 130.1, 129.0, 126.8, 50.9, 29.9, 21.4.
N-(2-(4-Bromophenyl)-2-iodoethyl)-4-methylben-
zenesulfonamide (2d)[8a]
1H NMR (400 MHz,
d6-DMSO) δ: 8.05 (t, J=6.0 Hz, 1H), 7.64 (d, J=8.4
Hz, 2H), 7.47 (d, J=8.4 Hz, 2H), 7.39-7.31 (m, 4H),
5.17-5.13 (m, 1H), 3.50-3.38 (m, 2H), 2.36 (s, 3H);
13C NMR (100 MHz, CDCl3) δ: 143.2, 140.9, 138.0,
131.9, 130.3, 130.1, 126.8, 121.5, 50.8, 29.9, 21.4.
N-(2-(2-Chlorophenyl)-2-iodoethyl)-4-methylben-
1
zenesulfonamide (2f) Colorless oil. H NMR (400
MHz, d6-DMSO) δ: 8.14 (t, J=6.0 Hz, 1H), 7.67 (d,
J=8.0 Hz, 2H), 7.60 (dd, J=8.4, 1.2 Hz, 1H), 7.41-
7.28 (m, 5H), 5.42-5.38 (m, 1H), 3.55-3.51 (m, 2H),
2.36 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 143.3,
138.4, 137.9, 132.6, 130.2, 130.1, 129.1, 128.3, 126.8,
49.6, 26.0, 21.4; IR (neat) v: 3285, 2920 cm−1; HRMS
(EI) calcd for C15H1535ClNO2S (M−I)+ 308.0512; found
308.0525.
4-Bromo-N-(2-iodo-2-phenylethyl)benzenesulfon-
N-(2-(3-Chlorophenyl)-2-iodoethyl)-4-methylben-
zenesulfonamide (2g) White solid 124-126 ℃; H
amide (2m) White solid 150-152 ℃; 1H NMR (400
1
Chin. J. Chem. 2013, 31, 1508—1512
© 2013 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1511